Русский

Pharmaceutical Industry Information Portal

HomeTagsBioXcel Therapeutics

All posts by tag

BioXcel Therapeutics

BioXcel Therapeutics logo

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.

World Pharma News

BioXcel Therapeutics raises funding from Oaktree Capital, Qatar’s Investment Authority

Techno -
BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,  April 19th announced strategic financing...
Regulatory News

Bioxcell Therapeutics announces FDA approval of IGALMI, the first new acute treatment for schizophrenia or bipolar disorder

Techno -
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop transformative medicines in neuroscience and immuno-oncology, on Wednesday announced...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories